{{Drugbox
| verifiedrevid = 447635722
| IUPAC_name = (17''R'',21Î²)-ajmalan-17,21-diol 17-chloroacetate<br />OR<br />(1''R'',9''R'',10''S'',13''R'',14''R'',16''S'',18''S'')-13-ethyl-8-methyl-14-hydroxy-8,15-diazahexacyclo [14.2.1.0<sup>1,9</sup>.0<sup>2,7</sup>.0<sup>10,15</sup>.0<sup>12,17</sup>]nonadeca-2(7),3,5-triene-18-yl chloroacetate
| image = Lorajmine skeletal.svg

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number = 47562-08-3
| CAS_supplemental =  
| ATC_prefix = C01
| ATC_suffix = BA12
| ATC_supplemental =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 16735878
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C22H27ClN2O3/c1-3-11-12-8-15-19-22(13-6-4-5-7-14(13)24(19)2)9-16(25(15)21(11)27)18(12)20(22)28-17(26)10-23/h4-7,11-12,15-16,18-21,27H,3,8-10H2,1-2H3/t11-,12-,15-,16-,18?,19-,20+,21+,22+/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = LAHDERDHXJFFJU-KBFYUGGWSA-N
| PubChem = 76957773
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = F96VX65849
| ChEMBL = 2111031

<!--Chemical data-->
| chemical_formula =  
| C=22 | H=27 | Cl=1 | N=2 | O=3 
| molecular_weight = 402.914 g/mol
| smiles = CCC1C2CC3C4C5(CC(C2C5C(=O)OCCl)N3C1O)C6=CC=CC=C6N4C
}}
'''Lorajmine''' (17-monochloroacetyl[[ajmaline]]) is a [[pharmaceutical drug|drug]] that is a potent [[sodium channel blocker]] (more specifically, a class Ia [[antiarrhythmic agent]]) that was used for treating [[arrhythmia]].<ref>[http://www.online-medical-dictionary.org/?q=Lorajmine Medical Dictionary Online: Lorajmine]</ref><ref>[[World Health Organization]]: [http://www.whocc.no/atc_ddd_index/?code=C01BA ATC/DDD Index]</ref> It is derived from ajmaline, an [[alkaloid]] from the roots of ''[[Rauwolfia serpentina]]'', by synthetically adding a [[chloroacetate]] residue.

== References ==
{{Reflist}}

{{Antiarrhythmic agents}}

[[Category:Sodium channel blockers]]
[[Category:Alcohols]]
[[Category:Carboxylate esters]]
[[Category:Indole alkaloids]]


{{cardiovascular-drug-stub}}